Chemoinformaics analysis of 9,12,15-Octadecatrienal
| Molecular Weight | 262.437 | nRot | 13 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 4 |
| Exact Molecular Weight | 262.23 | nRing | 0 |
| Solubility: LogS | -4.374 | nHRing | 0 |
| Solubility: LogP | 5.15 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 50.8658 |
| nHD | 0 | BPOL | 30.9642 |
| QED | 0.234 |
| Synth | 2.812 |
| Natural Product Likeliness | 1.559 |
| NR-PPAR-gamma | 0.306 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.001 |
| HIA | 0.03 |
| CACO-2 | -4.885 |
| MDCK | 0.0000226 |
| BBB | 0.003 |
| PPB | 0.988571 |
| VDSS | 2.076 |
| FU | 0.00732179 |
| CYP1A2-inh | 0.509 |
| CYP1A2-sub | 0.2 |
| CYP2c19-inh | 0.496 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.38 |
| CYP2c9-sub | 0.977 |
| CYP2d6-inh | 0.648 |
| CYP2d6-sub | 0.871 |
| CYP3a4-inh | 0.603 |
| CYP3a4-sub | 0.065 |
| CL | 2.861 |
| T12 | 0.828 |
| hERG | 0.074 |
| Ames | 0.006 |
| ROA | 0.001 |
| SkinSen | 0.982 |
| Carcinogencity | 0.085 |
| EI | 0.967 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.277 |
| Antiviral | Yes |
| Prediction | 0.648072 |